Clinical Trials in North Carolina

Showing 2621-2640 of 17,526 trials

Perioperative Continuous Glucose Monitoring

NCT05937373

To evaluate use of continuous glucose monitoring (CGM) technology in the preoperative setting: evaluate feasibility of placement of CGM during preoperative clinic visit with intent to utilize CGM throughout perioperative period.

Diabetes Mellitus

Wake Forest University Health Sciences22 participantsStarted Aug 2023

Winston-Salem, North Carolina, United States

RECRUITING41 miles

Stroke Thrombectomy and Aneurysm Registry

NCT04994756

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.

StrokeThromboses, IntracranialAneurysm, Brain

Medical University of South Carolina40,000 participantsStarted Sep 2019

Birmingham, Alabama, United States • Loma Linda, California, United States • Santa Barbara, California, United States +60 more locations

Perioperative Continuous Glucose Monitoring

Stroke Thrombectomy and Aneurysm Registry

Find Trials by Condition in North Carolina

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)

INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

SpineTRACK Registry - Spinal Outcomes Registry

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors